Physician profile
Bryan L Richards
NPI 1780660548
$6,371.60
in general payments reported to CMS, 2019-2025
24 companies · $2,321 in 2025
The $2,321 reported for 2025 was more than what 91% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $165 · 2020: $109 · 2021: $750 · 2022: $2,170 · 2023: $338 · 2024: $518 · 2025: $2,321.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,452 · Travel and Lodging: $725.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,452.41 |
| Travel and Lodging | $724.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $4,465.46 | 2021-2025 | Inspire |
| Aerin Medical INC. | $563.53 | 2022-2025 | |
| Genzyme Corporation | $289.90 | 2021-2025 | |
| Optinose US, INC. | $156.24 | 2019-2024 | |
| Glaxosmithkline, LLC. | $144.22 | 2021-2025 | Nucala |
| Medtronic, INC. | $138.44 | 2022-2025 | Propel, Stealthstation S8 Platform |
| Regeneron Healthcare Solutions, INC. | $136.64 | 2019-2025 | Dupixent |
| Intersect Ent, INC. | $102.80 | 2019-2021 | |
| Depuy Synthes Sales INC. | $81.12 | 2022 | |
| Acclarent, INC | $53.65 | 2019 | |
| Stryker Corporation | $24.86 | 2021 | |
| Baxter Healthcare | $24.06 | 2024 | Perclot |
| Phadia US INC. | $21.70 | 2019 | |
| Highridge Medical LLC | $20.30 | 2025 | Biomet Ebi Bone Healing System |
| Ebi, LLC | $20.30 | 2025 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $18.94 | 2023 | Vabysmo |
| Tactile Systems Technology INC | $17.06 | 2025 | Flexitouch Plus, Nimbl |
| Merck Sharp & Dohme LLC | $15.33 | 2023 | |
| Solventum Corporation | $13.37 | 2024 | Prevena |
| Kaleo, INC. | $13.26 | 2023 | Auvi-Q |
| Phathom Pharmaceuticals, INC. | $13.10 | 2024 | Voquezna |
| Astrazeneca Pharmaceuticals LP | $12.98 | 2021 | |
| Cook Medical LLC | $12.42 | 2020 | |
| Smith+Nephew, INC. | $11.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Richards listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.